NDC 83932-290 - CASGEVY

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 83932-290
Package NDCs from labels: 83932-290-01, 83932-290-09
Manufacturer: Roslin Cell Therapies Limited
Effective date: 2024-09-06
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
CASGEVY - Roslin Cell Therapies Limited	Roslin Cell Therapies Limited	2024-09-06	CELLULAR THERAPY

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
83932-290	CASGEVY (EXAGAMGLOGENE AUTOTEMCEL) INJECTION, SUSPENSION [ROSLIN CELL THERAPIES LIMITED]	1	Unmatched	20240910_bd2ea021-ee99-4844-96c6-9b7f24a12767.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CASGEVY	EXAGAMGLOGENE AUTOTEMCEL	Vertex Pharmaceuticals Incorporated	7c3e12ad-e2fe-4d3f-a630-ea7364d9e846	2026-07-07	Warnings, Adverse reactions	Exact identifier unii: S53L777GM8
37da51d9-c6e7-fe1f-e063-6294a90a87f9			bd2ea021-ee99-4844-96c6-9b7f24a12767	2025-06-18	Warnings, Adverse reactions	Exact identifier spl set id: bd2ea021-ee99-4844-96c6-9b7f24a12767

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.